Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Richard L. Tower MD

Richard L. Tower MD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology/Oncology
Program: Oncology

Member of the Cancer Center


  • Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group. (Tower RL, Jones TL, Camitta BM, Asselin BL, Bell BA, Chauvenet A, Devidas M, Halperin EC, Pullen J, Shuster JJ, Winick N, Kurtzberg J) J Pediatr Hematol Oncol 2014 Jul;36(5):353-61 PMID 24608079
  • Significant response to oral Etoposide in the treatment of an unresectable cardiac sarcoma. (Collins CL, Bartz PJ, Lal DR, Segura AD, Woods RK, Tower RL 2nd) J Pediatr Hematol Oncol 2014 May;36(4):e237-40 PMID 23652877
  • Case report: giant cardiac malignancy in a nine-year-old female. (Scott JP, Troshynski TJ, Clarke WR, Woods RK, Lal DR, Berens RJ, Tower RL) Can J Anaesth 2012 Nov;59(11):1048-51 PMID 22936572
  • Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report. (Ross JA, Linabery AM, Blommer CN, Langer EK, Spector LG, Hilden JM, Heerema NA, Radloff GA, Tower RL, Davies SM) Pediatr Blood Cancer 2013 Jan;60(1):31-4 PMID 22422485
  • A composite pheochromocytoma/ganglioneuroblastoma of the adrenal gland. (Thiel EL, Trost BA, Tower RL) Pediatr Blood Cancer 2010 Jul 1;54(7):1032-4 PMID 20162688
  • The epidemiology of childhood leukemia with a focus on birth weight and diet. (Tower RL, Spector LG) Crit Rev Clin Lab Sci 2007;44(3):203-42 PMID 17453918
  • Last update: 02/04/2015